approval
saveVRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approval
community read0 votes
Sponsor: ABBVIE. Form: CAPSULE. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalVRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approvalDec 18, 2025 · 290d ago
- approvalVRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approvalDec 18, 2025 · 290d ago
- approvalVRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approvalDec 18, 2025 · 290d ago
- approvalVRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approvalDec 18, 2025 · 290d ago
- approvalCARIPRAZINE HYDROCHLORIDE — FDA approvalDec 16, 2025 · 292d ago
- approvalVRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approvalNov 22, 2024 · 681d ago
- approvalVRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approvalMay 24, 2019 · 2690d ago
- approvalVRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approvalNov 28, 2018 · 2867d ago
same company · ±60 days · 4
- approvaldexamethasone LA: OZURDEX (DEXAMETHASONE) — FDA approvalDec 19, 2022
- approvalprednisolone acetate: PRED MILD (PREDNISOLONE ACETATE) — FDA approvalDec 8, 2022
- approvalprednisolone acetate: PRED MILD (PREDNISOLONE ACETATE) — FDA approvalDec 8, 2022
- approvalupadacitinib tartrate ER: RINVOQ (UPADACITINIB) — FDA approvalOct 21, 2022
comments(0)
5-min edit window · permanent after that